Brefel-Courbon C - Search Results

1

Dopaminergic denervation using [¹²³I]-FPCIT and pain in Parkinson's disease: a correlation study.

Dellapina E, Pellaprat J, Adel D, Llido J, Harroch E, Martini JB, Kas A, Salabert AS, Ory-Magne F, Payoux P, Brefel-Courbon C. Dellapina E, et al. J Neural Transm (Vienna). 2019 Mar;126(3):279-287. doi: 10.1007/s00702-019-01974-5. Epub 2019 Jan 31. J Neural Transm (Vienna). 2019. PMID: 30706197

2

The management of patients with early Parkinson's disease.

Rascol O, Payoux P, Ferreira J, Brefel-Courbon C. Rascol O, et al. Parkinsonism Relat Disord. 2002 Oct;9(1):61-7. doi: 10.1016/s1353-8020(02)00045-7. Parkinsonism Relat Disord. 2002. PMID: 12217623 Review.

3

The management of patients with early Parkinson's disease.

Rascol O, Brefel-Courbon C, Payoux P, Ferreira J. Rascol O, et al. Adv Neurol. 2003;91:203-11. Adv Neurol. 2003. PMID: 12442679 Review. No abstract available.

4

Limitations of current Parkinson's disease therapy.

Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL. Rascol O, et al. Ann Neurol. 2003;53 Suppl 3:S3-12; discussion S12-5. doi: 10.1002/ana.10513. Ann Neurol. 2003. PMID: 12666094 Review.

5

Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.

Courbon F, Brefel-Courbon C, Thalamas C, Alibelli MJ, Berry I, Montastruc JL, Rascol O, Senard JM. Courbon F, et al. Mov Disord. 2003 Aug;18(8):890-7. doi: 10.1002/mds.10461. Mov Disord. 2003. PMID: 12889078

6

Cortical motor activation in akinetic schizophrenic patients: a pilot functional MRI study.

Payoux P, Boulanouar K, Sarramon C, Fabre N, Descombes S, Galitsky M, Thalamas C, Brefel-Courbon C, Sabatini U, Manelfe C, Chollet F, Schmitt L, Rascol O. Payoux P, et al. Mov Disord. 2004 Jan;19(1):83-90. doi: 10.1002/mds.10598. Mov Disord. 2004. PMID: 14743365

7

Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.

Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, Montastruc JL, Rascol O. Brefel-Courbon C, et al. Mov Disord. 2005 Dec;20(12):1557-63. doi: 10.1002/mds.20629. Mov Disord. 2005. PMID: 16078219 Clinical Trial.

8

[Levodopa modifies pain thresholds in Parkinson's disease patients].

Slaoui T, Mas-Gerdelat A, Ory-Magne F, Rascol O, Brefel-Courbon C. Slaoui T, et al. Rev Neurol (Paris). 2007 Jan;163(1):66-71. doi: 10.1016/s0035-3787(07)90356-2. Rev Neurol (Paris). 2007. PMID: 17304174 Clinical Trial. French.

9

Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy.

Brefel-Courbon C, Payoux P, Ory F, Sommet A, Slaoui T, Raboyeau G, Lemesle B, Puel M, Montastruc JL, Demonet JF, Cardebat D. Brefel-Courbon C, et al. Ann Neurol. 2007 Jul;62(1):102-5. doi: 10.1002/ana.21110. Ann Neurol. 2007. PMID: 17357126 Clinical Trial.

10

Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study.

Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, Ory-Magne F, Slaoui T, Rascol O, Brefel-Courbon C. Gerdelat-Mas A, et al. J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1140-2. doi: 10.1136/jnnp.2007.120212. Epub 2007 May 15. J Neurol Neurosurg Psychiatry. 2007. PMID: 17504881 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page